Drugs / non-polarized dendritic cells
last change Jan 2015 re-read 3 minutes ago

non-polarized dendritic cells

Cell therapy

Developed for
cutaneous melanoma
Investigated by
National Cancer Institute (NCI) · Pawel Kalinski

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00390338 Oct 2006 → May 2012 cutaneous melanoma Pawel Kalinski Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as non-polarized dendritic cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT00390338 ↗
Modality Cell therapy “autologous mature dendritic cell vaccine” NCT00390338 ↗
Route Other “intralymphatic vaccination with peptide-pulsed mature non-polarized dendritic cells (cDCs)” NCT00390338 ↗